
Prospects of 2nd line chemotherapy personalization in patients with metastatic castration-resistant prostate cancer
Author(s) -
B. Ya. Alekseev,
K. M. Nyushko
Publication year - 2016
Publication title -
onkourologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 4
eISSN - 1996-1812
pISSN - 1726-9776
DOI - 10.17650/1726-9776-2016-12-4-104-109
Subject(s) - medicine , cabazitaxel , prostate cancer , taxane , oncology , docetaxel , chemotherapy , hormonal therapy , androgen deprivation therapy , abiraterone acetate , metastatic breast cancer , testosterone (patch) , cancer , breast cancer